prostate: hormone- sensitive (including...
TRANSCRIPT
![Page 1: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/1.jpg)
Prostate: Hormone-sensitive (including
localized) Oral presentations
Dott. Luca Galli
U.O. Oncologia Medica 2 Universitaria
Azienda Ospedaliero-Universitaria Pisana
Pisa
![Page 2: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/2.jpg)
![Page 3: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/3.jpg)
Elegibility
![Page 4: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/4.jpg)
Study schema
![Page 5: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/5.jpg)
Objectives
![Page 6: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/6.jpg)
Patient Baseline Characteristics
![Page 7: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/7.jpg)
Summary of Adverse Events
![Page 8: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/8.jpg)
Leukemia Summary slide
![Page 9: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/9.jpg)
Cause of Death
![Page 10: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/10.jpg)
ITT Disease Free Survival
![Page 11: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/11.jpg)
Overall Survival
>80% vivi a 10 anni
![Page 12: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/12.jpg)
Conclusions
![Page 13: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/13.jpg)
![Page 14: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/14.jpg)
Background
![Page 15: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/15.jpg)
Purpose Moving forward…
To evaluate whether the Decipher genomic classifier determined
from biopsy specimens is prognostic for mets and PCSM in a mixed cohort treated with RP
and RT ± ADT
![Page 16: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/16.jpg)
Patients
![Page 17: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/17.jpg)
Results
High 20%
Int Low
![Page 18: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/18.jpg)
Results
![Page 19: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/19.jpg)
Results
![Page 20: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/20.jpg)
Results
![Page 21: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/21.jpg)
Results
![Page 22: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/22.jpg)
Future perspectives
![Page 23: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/23.jpg)
Conclusions
Too few low risk pts for use in the decision between surveillance vs treatment
![Page 24: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/24.jpg)
![Page 25: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/25.jpg)
Background and hypotheses
![Page 26: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/26.jpg)
Methods
![Page 27: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/27.jpg)
Results
NO HER-2 subtype!
![Page 28: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/28.jpg)
Results
![Page 29: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/29.jpg)
Results
![Page 30: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/30.jpg)
What’s behind all this?
![Page 31: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/31.jpg)
Clinical implications?
**ADT given either adjuvant or early salvage post prostatectomy
* *
![Page 32: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/32.jpg)
Can PAM50 give us something more?
![Page 33: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/33.jpg)
Can PAM50 give us something more?
![Page 34: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/34.jpg)
Future perspectives
![Page 35: Prostate: Hormone- sensitive (including localized)media.aiom.it/userfiles/files/doc/AIOM-Servizi/slide/20170303MI_13... · Adjuvant androgen deprivation (ADT) versus mitoxantrone](https://reader035.vdocuments.site/reader035/viewer/2022071219/60f6a4b9f63f9a7b9f118039/html5/thumbnails/35.jpg)
Conclusions